`
`Investors: Gilead News Release
`
`Print Page | Close Window
`Gilead Sciences to Present at the 7th Annual Lehman Brothers Global Healthcare
`Conference on Friday, March 5th; Webcast Available Through Gilead Corporate Website
`
`FOSTER CITY, Calif.--(BUSINESS WIRE)--March 4, 2004--Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its
`corporate presentation will be webcast from the 7th Annual Lehman Brothers Global Healthcare Conference in Miami Beach,
`Florida. This webcast may be accessed via the company's corporate website at www.gilead.com.
`
`John Milligan, PhD, Gilead's Executive Vice President and Chief Financial Officer, will provide an overview of the company and
`an update on key business milestones on Friday, March 5th at 8:30 a.m. Eastern Time.
`
`To access the live webcast via the internet log on to www.gilead.com. Please connect to the company's website at least 15
`minutes prior to the live presentation to ensure adequate time for any software download that may be necessary to view the
`webcast.
`
`Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the
`care of patients suffering from life-threatening diseases worldwide. The company has six marketed products and focuses its
`research and clinical programs on anti-infectives. Headquartered in Foster City, CA, Gilead has operations in the United States,
`Europe and Australia.
`
`For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-
`GILEAD-5 (1-800-445-3235).
`
`CONTACT: Gilead Sciences, Inc.
`Susan Hubbard, 650-522-5715 (Investor Relations)
`
`SOURCE: Gilead Sciences, Inc.
`
`http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-newsArticle_Print&ID=501785
`
`1/1